Genome-Scale Screening of Drug-Target Associations Relevant to Ki Using a Chemogenomics Approach

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Cao, Dong Sheng ^a   Liang, Yi Zeng ^a   Deng, Zhe ^b   Hu, Qian Nan ^b   He, Min ^a   Xu, Qing Song ^a   Zhou, Guang Hua ^c   Zhang, Liu Xia ^c   Deng, Zi xin ^b   Liu, Shao ^d  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c The 163rd Hospital of The Chinese People's Liberation Army   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BINDING AFFINITY; CHEMOGENOMICS; COMPUTER PROGRAM; DRUG INTERACTION; DRUG PROTEIN BINDING; DRUG TARGET ASSOCIATION; GENOMICS; PREDICTION; QUANTITATIVE ANALYSIS; RANDOM FOREST; STATISTICAL MODEL; VALIDITY;

DRUG EVALUATION, PRECLINICAL; GENOMICS; HUMANS; PHARMACEUTICAL PREPARATIONS; PROBABILITY; PROTEIN BINDING; PROTEINS; ROC CURVE;

EID: 84875927922     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057680     Document Type: Article

References (72)

1. Kuhn M, Campillos M, Gonzolez P, Jensen LJ, Bork P, (2008) Large-scale prediction of drug-target relationships. FEBS letters 582: 1283-1290.
2. Yildirim MA, Goh KI, Cusick ME, Barabsi AL, Vidal M, (2007) Drug-target network. Nat Biotechnol 25: 1119-1126.
3. Paolini GV, Shapland RHB, van Hoorn WP, Mason JS, Hopkins AL, (2006) Global mapping of pharmacological space. Nat Biotech 24: 805-815.
4. Yao L, Evans JA, Rzhetsky A, (2009) Novel opportunities for computational biology and sociology in drug discovery: Corrected paper. Trends in Biotechnology 28: 161-170.
5. Ashburn TT, Thor KB, (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3: 673-683.
6. Dudley JT, Deshpande T, Butte AJ, (2011) Exploiting drug-disease relationships for computational drug repositioning. Briefings in Bioinformatics 12: 303-311.
7. Dunkel M, Gunther S, Ahmed J, Wittig B, Preissner R, (2008) SuperPred: drug classification and target prediction. Nucleic Acids Research 36: W55-W59.
8. Sanseau P, Koehler J, (2011) Editorial: Computational methods for drug repurposing. Briefings in Bioinformatics 12: 301-302.
9. Barabasi A-L, Oltvai ZN, (2004) Network biology: understanding the cell's functional organization. Nat Rev Genet 5: 101-113.
10. Dive C, Hickman JA, (1991) Drug-target interactions: only the first step in the commitment to a programmed cell death? Br J Cancer 64: 192-196.
11. Mestres J, Gregori-Puigjane E, Valverde S, Sole RV, (2009) The topology of drug-target interaction networks: implicit dependence on drug properties and target families. Molecular BioSystems 5: 1051-1057.
12. Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, et al. (2007) Relating protein pharmacology by ligand chemistry. Nat Biotech 25: 197-206.
13. Campillos M, Kuhn M, Gavin AC, Jensen LJ, Bork P, (2008) Drug target identification using side-effect similarity. Science 321: 263-266.
14. Shoichet BK, McGovern SL, Wei B, Irwin JJ, (2002) Lead discovery using molecular docking. Curr Opin Chem Biol 6: 439-446.
15. Luo H, Chen J, Shi L, Mikailov M, Zhu H, et al. (2011) DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome. Nucleic Acids Research 39: W492-W498.
16. Irwin JJ, Shoichet BK, Mysinger MM, Huang N, Colizzi F, et al. (2009) Automated Docking Screens: A Feasibility Study. Journal of Medicinal Chemistry 52: 5712-5720.
17. Goodsell DS, Morris GM, Olson AJ, (1996) Automated docking of flexible ligands: Applications of autodock. Journal of Molecular Recognition 9: 1-5.
18. Jacob L, Vert JP, (2008) Protein-ligand interaction prediction: an improved chemogenomics approach. Bioinformatics 24: 2149-2156.
19. Xia Z, Wu L-Y, Zhou X, Wong S (2010) Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces. BMC Systems Biology (Suppl 2): S6.
20. He Z, Zhang J, Shi X-H, Hu L-L, Kong X, et al. (2010) Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features. PLoS ONE 5: e9603.
21. Yu W, Cheng X, Li Z, Jiang Z, (2011) Predicting drug-target interactions based on an improved semi-supervised learning approach. Drug Development Research 72: 219-224.
22. Wang F, Liu D, Wang H, Luo C, Zheng M, et al. (2011) Computational Screening for Active Compounds Targeting Protein Sequences: Methodology and Experimental Validation. Journal of Chemical Information and Modeling 51: 2821-2828.
23. Ben-Hur A, Noble WS, (2005) Kernel methods for predicting protein-protein interactions. Bioinformatics 21: i38-i46.
24. Jacob L, Hoffmann B, Stoven V, Vert J-P, (2008) Virtual screening of GPCRs: An in silico chemogenomics approach. BMC Bioinformatics 9: 363.
25. Bleakley K, Yamanishi Y, (2009) Supervised prediction of drug-target interactions using bipartite local models. Bioinformatics 25: 2397-2403.
26. van Laarhoven T, Nabuurs SB, Marchiori E, (2011) Gaussian interaction profile kernels for predicting drug-target interaction. Bioinformatics 27: 3036-3043.
27. Nunez S, Venhorst J, Kruse CG, (2011) Target-drug interactions: first principles and their application to drug discovery. Drug Discovery Today 17: 10-22.
28. Hopkins AL, Groom CR, Alex A, (2004) Ligand efficiency: a useful metric for lead selection. Drug Discovery Today 9: 430-431.
29. Carlson H, Dunbar JJ, (2011) A call to arms: what you can do for computational drug discovery. J Chem Inf Model 51: 2025-2026.
30. Bredel M, Jacoby E, (2004) Chemogenomics: an emerging strategy for rapid target and drug discovery. Nat Rev Genet 5: 262-275.
31. Zhang H, Yu C-Y, Singer B, (2003) Cell and tumor classification using gene expression data: Construction of forests. Proceedings of the National Academy of Sciences 100: 4168-4172.
32. Li X, Rao S, Wang Y, Gong B, (2004) Gene mining: a novel and powerful ensemble decision approach to hunting for disease genes using microarray expression profiling. Nucleic Acids Research 32: 2685-2694.
33. Shi T, Seligson D, Belldegrun AS, Palotie A, Horvath S, (2004) Tumor classification by tissue microarray profiling: random forest clustering applied to renal cell carcinoma. Mod Pathol 18: 547-557.
34. Wu J, Liu H, Duan X, Ding Y, Wu H, et al. (2009) Prediction of DNA-binding residues in proteins from amino acid sequences using a random forest model with a hybrid feature. Bioinformatics 25: 30-35.
35. Hopkins AL, (2007) Network pharmacology. Nat Biotech 25: 1110-1111.
36. Hopkins AL, (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4: 682-690.
37. Jahnke W, Erlanson DA (2006) Fragment-based Approaches in Drug Discovery; Mannhold R, Kubinyi H, Folkers G, editors. Weinheim: Wiley-VCH.
38. Fawcett T, (2006) An introduction to ROC analysis. Pattern Recognition Letters 27: 861-874.
39. Sing T, Sander O, Beerenwinkel N, Lengauer T, (2005) ROCR: visualizing classifier performance in R. Bioinformatics. 21: 3940-3941.
40. Boulesteix A-L, Bender A, Lorenzo Bermejo J, Strobl C, (2011) Random forest Gini importance favours SNPs with large minor allele frequency: impact, sources and recommendations. Briefings in Bioinformatics 13: 292-304.
41. Chen X-W, Liu M, (2005) Prediction of protein-protein interactions using random decision forest framework. Bioinformatics 21: 4394-4400.
42. Diaz-Uriarte R, Alvarez de Andres S, (2006) Gene selection and classification of microarray data using random forest. BMC Bioinformatics 7: 3.
43. Wang Y, Bolton E, Dracheva S, Karapetyan K, Shoemaker BA, et al. (2010) An overview of the PubChem BioAssay resource. Nucleic Acids Research 38: D255-D266.
44. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, et al. (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Research 40 (D1): D1100-D1107.
45. Overington JP, Al-Lazikani B, Hopkins AL, (2006) How many drug targets are there? Nat Rev Drug Discov 5: 993-996.
46. Roth BL, Sheffler D, Potkin SG, (2003) Atypical antipsychotic drug actions: unitary or multiple mechanisms for 'atypicality'? Clinical Neuroscience Research 3: 108-117.
47. Chen J-C, Smith ER, Cahill M, Cohen R, Fishman JB, (1993) The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine. Life Sciences 52: 389-396.
48. Kristensen K, Christensen CB, Christrup LL, (1994) The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sciences 56: 45-50.
49. Roth BL, Sheffler DJ, Kroeze WK, (2004) Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 3: 353-359.
50. Goudie AJ, Halford JCG, Dovey TM, Cooper GD, Neill JC, (2003) H1-histamine Receptor Affinity Predicts Short-term Weight Gain for Typical and Atypical Antipsychotic Drugs. Neuropsychopharmacology 28: 2209-2209.
51. Harris CJ, Stevens AP, (2006) Chemogenomics: structuring the drug discovery process to gene families. Drug Discovery Today 11: 880-888.
52. Mestres J, (2004) Computational chemogenomics approaches to systematic knowledge-based drug discovery. Current opinion in drug discovery & development 7: 304-313.
53. Rognan D, (2007) Chemogenomic approaches to rational drug design. British Journal of Pharmacology 152: 38-52.
54. Martin YC, Kofron JL, Traphagen LM, (2002) Do Structurally Similar Molecules Have Similar Biological Activity? Journal of Medicinal Chemistry 45: 4350-4358.
55. Klabunde T, (2007) Chemogenomic approaches to drug discovery: similar receptors bind similar ligands. British Journal of Pharmacology 152: 5-7.
56. Folger O, Jerby L, Frezza C, Gottlieb E, Ruppin E, et al. (2011) Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol 7: 501.
57. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, et al. (2006) The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease. Science 313: 1929-1935.
58. Lamb J, (2007) The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer 7: 54-60.
59. van Westen GJP, Wegner JK, Geluykens P, Kwanten L, Vereycken I, et al. (2011) Which Compound to Select in Lead Optimization? Prospectively Validated Proteochemometric Models Guide Preclinical Development. PLoS ONE 6: e27518.
60. Pittman J, Sacks J, Young SS, (2002) The Construction and Assessment of a Statistical Model for the Prediction of Protein Assay Data. Journal of Chemical Information and Computer Sciences 42: 729-741.
61. Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK, (2007) BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Research 35: D198-D201.
62. Rask-Andersen M, Almen MS, Schioth HB, (2011) Trends in the exploitation of novel drug targets. Nat Rev Drug Discov 10: 579-590.
63. Knox C, Law V, Jewison T, Liu P, Ly S, et al. (2010) DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs. Nucleic Acids Research 39: D1035-D1041.
64. Yamanishi Y, Araki M, Gutteridge A, Honda W, Kanehisa M, (2008) Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics 24: i232-i240.
65. Block P, Sotriffer CA, Dramburg I, Klebe G, (2005) AffinDB: a freely accessible database of affinities for protein- ligand complexes from the PDB. Nucleic Acids Research 34: D522-D526.
66. Huang N, Shoichet BK, Irwin JJ, (2006) Benchmarking Sets for Molecular Docking. Journal of Medicinal Chemistry 49: 6789-6801.
67. Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, et al. (2009) Predicting new molecular targets for known drugs. Nature 462: 175-181.
68. Breiman L, (2001) Random forests. Machine Learning 45: 5-32.
69. Svetnik V, Liaw A, Tong C, Culberson JC, Sheridan RP, et al. (2003) Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling. Journal of Chemical Information and Computer Sciences 43: 1947-1958.
70. Breiman L, Friedman JH, Olsen RA, Stone CJ (1984) Classification and Regression Trees. California: Wadsworth International.
71. Dubchak I, Muchnik I, Holbrook SR, Kim SH, (1995) Prediction of protein folding class using global description of amino acid sequence. Proceedings of the National Academy of Sciences 92: 8700-8704.
72. Kawashima S, Kanehisa M, (1999) AAindex: Amino Acid index database. Nucleic Acids Research 27: 368-369.